Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Paul Haluska

Can We Unlock the Potential of IGF-1R Inhibition in Cancer Therapy?

Cancer Treatment Reviews

Nuclear Medicine

English

Phase II Trial of Lapatinib and Topotecan (LapTop) in Patients With Platinum-Refractory/Resistant Ovarian and Primary Peritoneal Carcinoma

Gynecologic Oncology

English

In Vivo Anti-Tumor Activity of the PARP Inhibitor Niraparib in Homologous Recombination Deficient and Proficient Ovarian Carcinoma

Gynecologic Oncology

English

Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment

Frontiers in Oncology

Cancer Research

English

Phase I Study of 17-Allylamino-17 Demethoxygeldanamycin, Gemcitabine and/or Cisplatin in Patients With Refractory Solid Tumors

Investigational New Drugs

English

The Insulin-Like Growth Factor System in Cancer

Endocrinology and Metabolism Clinics of North America

English

Gene Expression Differences Between Matched Pairs of Ovarian Cancer Patient Tumors and Patient-Derived Xenografts

Scientific Reports

Multidisciplinary

English

Safety, Tolerability, and Pharmacokinetics of the Anti-Igf-1r Monoclonal Antibody Figitumumab in Patients With Refractory Adrenocortical Carcinoma

Cancer Chemotherapy and Pharmacology

Cancer Research

English